Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Malgorzata Walentowicz-Sadlecka

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Open Medicine (Warsaw, Poland)|June 11, 2024
Molecular landscape of borderline ovarian tumours: A systematic reviewPawel Sadlecki, Malgorzata Walentowicz-Sadlecka
Open Medicine (Warsaw, Poland)|May 17, 2023
Prenatal diagnosis of fetal defects and its implications on the delivery modePawel Sadlecki, Malgorzata Walentowicz-Sadlecka
Journal of Robotic Surgery|August 19, 2025
Hysterectomy for oncological and non-oncological reasons in patients over 70 years of age - comparison of robot-assisted, laparoscopic, and open approachesPawel Sadlecki, Malgorzata Walentowicz-Sadlecka
Archives of Gynecology and Obstetrics|July 24, 2024
Feasibility evaluation of the Versius surgical system: robot-assisted hysterectomy for benign and malignant gynaecological lesionsPawel Sadlecki, Malgorzata Walentowicz-Sadlecka
Open Medicine (Warsaw, Poland)|April 13, 2026
Umbilical port-site endometriosis: a case presentation and narrative review of the literaturePawel Sadlecki, Katarzyna Dejewska, Malgorzata Walentowicz-Sadlecka
Plos One|September 30, 2016
Prenatal Clinical Assessment of NT-proBNP as a Diagnostic Tool for Preeclampsia, Gestational Hypertension and Gestational Diabetes MellitusPawel Sadlecki, Marek Grabiec, Malgorzata Walentowicz-Sadlecka
Open Medicine (Warsaw, Poland)|September 8, 2025
Giant borderline ovarian tumours - review of the literaturePawel Sadlecki, Katarzyna Dejewska, Patrycja Domieracka, et al.
BMC Pregnancy and Childbirth|May 18, 2018
Why do patients decline amniocentesis? Analysis of factors influencing the decision to refuse invasive prenatal testingPawel Sadlecki, Marek Grabiec, Pawel Walentowicz, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 11, 2017
KRAS mutation testing in borderline ovarian tumors and low-grade ovarian carcinomas with a rapid, fully integrated molecular diagnostic systemPawel Sadlecki, Paulina Antosik, Dariusz Grzanka, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 23, 2013
Altered expression of ERs, aromatase, and COX2 connected to estrogen action in type 1 endometrial cancer biologyKatarzyna Jarzabek, Mariusz Koda, Malgorzata Walentowicz-Sadlecka, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Open Medicine (Warsaw, Poland)|June 11, 2024
Molecular landscape of borderline ovarian tumours: A systematic reviewPawel Sadlecki, Malgorzata Walentowicz-Sadlecka
Open Medicine (Warsaw, Poland)|May 17, 2023
Prenatal diagnosis of fetal defects and its implications on the delivery modePawel Sadlecki, Malgorzata Walentowicz-Sadlecka
Journal of Robotic Surgery|August 19, 2025
Hysterectomy for oncological and non-oncological reasons in patients over 70 years of age - comparison of robot-assisted, laparoscopic, and open approachesPawel Sadlecki, Malgorzata Walentowicz-Sadlecka
Archives of Gynecology and Obstetrics|July 24, 2024
Feasibility evaluation of the Versius surgical system: robot-assisted hysterectomy for benign and malignant gynaecological lesionsPawel Sadlecki, Malgorzata Walentowicz-Sadlecka
Open Medicine (Warsaw, Poland)|April 13, 2026
Umbilical port-site endometriosis: a case presentation and narrative review of the literaturePawel Sadlecki, Katarzyna Dejewska, Malgorzata Walentowicz-Sadlecka
Plos One|September 30, 2016
Prenatal Clinical Assessment of NT-proBNP as a Diagnostic Tool for Preeclampsia, Gestational Hypertension and Gestational Diabetes MellitusPawel Sadlecki, Marek Grabiec, Malgorzata Walentowicz-Sadlecka
Open Medicine (Warsaw, Poland)|September 8, 2025
Giant borderline ovarian tumours - review of the literaturePawel Sadlecki, Katarzyna Dejewska, Patrycja Domieracka, et al.
BMC Pregnancy and Childbirth|May 18, 2018
Why do patients decline amniocentesis? Analysis of factors influencing the decision to refuse invasive prenatal testingPawel Sadlecki, Marek Grabiec, Pawel Walentowicz, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 11, 2017
KRAS mutation testing in borderline ovarian tumors and low-grade ovarian carcinomas with a rapid, fully integrated molecular diagnostic systemPawel Sadlecki, Paulina Antosik, Dariusz Grzanka, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 23, 2013
Altered expression of ERs, aromatase, and COX2 connected to estrogen action in type 1 endometrial cancer biologyKatarzyna Jarzabek, Mariusz Koda, Malgorzata Walentowicz-Sadlecka, et al.
Pageof 2